Journal Guide

Evolutionary Applications is a fully peer reviewed open access journal. It publishes papers that utilize concepts from evolutionary biology to address biological questions of health, social and economic relevance. Papers are expected to employ evolutionary concepts or methods to make contributions to areas such as (but not limited to): medicine, agriculture, forestry, exploitation and management (fisheries and wildlife), aquaculture, conservation biology, environmental sciences (including climate change and invasion biology), microbiology, and toxicology. All taxonomic groups are covered from microbes, fungi, plants and animals. In order to better serve the community, we also now strongly encourage submissions of papers making use of modern molecular and genetic methods (population and functional genomics, transcriptomics, proteomics, epigenetics, quantitative genetics, association and linkage mapping) to address important questions in any of these disciplines and in an applied evolutionary framework. Theoretical, empirical, synthesis or perspective papers are welcome.

Evolutionary Applications is now part of the Wiley Open Access publishing program of fully open access journals published by Wiley. For further information visit the Wiley Open Access website.

An international, peer-reviewed journal focusing on evolutionary bioinformatics. There is growing awareness that to understand organismal form and function, through the use of molecular, genetic, genomic, and proteomic data, due consideration must be given to an organism's evolutionary context - history constrains the path an organism is obliged to take, and leaves an indelible mark on its component parts. Evolutionary Bioinformatics publishes papers on all aspects of computational evolutionary biology and evolutionary bioinformatics.

Exercise and Sport Sciences Reviews: the Official Review Journal of the American College of Sports Medicine, consists of brief reviews for readers with a broad interest in scientific issues related to exercise, movement, physical activity and/or sports. Continuously highly ranked in Sport Sciences (2008 Journal Citation Reports174;, Thomson Reuters, 2009), this publication emphasizes interdisciplinary topics that highlight the integrative nature of contemporary research in exercise and sports sciences. For more information, visit www.acsm-essr.com.Individual and In-Training subscribers receive fully searchable online access to articles from Volume 1 to the present8212;now available on a powerful new website! This best-in-class website platform uses Web 2.0 functionality to provide an enhanced online experience through such features as: saved searches, personal article collections, easy image downloads to PowerPoint, and more.ACSM members receive Exercise and Sport Sciences Reviews as one of their core member benefit publications. For membership information, please visit www.acsm.org.

EXPERIMENTAL and MOLECULAR MEDICINE, EMM, publishes research papers and a limited number of reviews in the fields of basic and applied molecular biology, and experimental biochemistry in medicine. Research areas include analysis of gene structure, function and regulation; molecular mechanisms of genetic recombination; recombinant nucleic acid technology and gene therapy. EMM is also dedicated to the experimental biochemistry in medicine, including the regulatory mechanisms of body functions; structural biology and interaction between proteins and/or nucleic acids. Although special research areas are emphasized for publication, articles dealing with molecular biology and experimental biochemistry in other areas will also be welcomed.

Experimental Aging Research is a life span developmental and aging journal dealing with research on the aging process from a psychological and psychobiological perspective. It meets the need for a scholarly journal with refereed scientific papers dealing with age differences and age changes at any point in the adult life span. Areas of major focus include experimental psychology, neuropsychology, psychobiology, work research, ergonomics, and behavioral medicine. Original research, book reviews, monographs, and papers covering special topics are published. Peer Review Policy: All review papers in this journal have undergone editorial screening and peer review. Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.

Experimental Biology and Medicine is a journal dedicated to the publication of multidisciplinary and interdisciplinary research in the biomedical sciences. Published monthly, EBM provides both research and review articles as well as meeting symposia and brief communications. Articles in EBM represent cutting edge research at the overlapping junctions of the biological, physical and engineering sciences that impact upon the health and welfare of the world's population. Topics covered in EBM include: Anatomy/Pathology; Biochemistry and Molecular Biology; Cell and Developmental Biology; Endocrinology and Nutrition; Immunology/Microbiology/Virology; Neuroscience; Pharmacology and Toxicology; Physiology; Bioimaging; Biomedical Engineering; Bionanoscience; Genomics, Proteomics, and Bioinformatics; Stem Cell Biology; Systems Biology, and Translational Research.

Experimental Cell Research promotes the understanding of cell biology by publishing experimental studies on the general organization and activity of cells. The scope of the journal includes all aspects of cell biology, from the molecular level to the level of cell interaction and differentiation.Experimental Cell Research publishes papers in the area of cell and molecular biology, and papers must provide novel and significant insights into important problems in these areas. Areas of interest include, but are not restricted to:- Apoptosis and programmed cell death- Cancer research- Cell cycle- Cell proliferation and differentiation- Cellular motility and migration- Cell-cell and cell-matrix interaction- Chromatin- Chromosome structure and dynamics- Cytoskeleton- Developmental biology- DNA repair- Epigenetics- Extracellular matrix- Gene regulation- Intracellular trafficking- Mammalian genetic models- Meiosis and mitosis- MicroRNA- Nuclear import-export- RNA processing- Signal transduction- Stem cell biology- Subcellular organizationExperimental Cell Research has partnered with Gastroenterologyhttp://www.gastrojournal.org/ to offer fast track review for certain articles. Articles rejected from Gastroenterology because of their strong biological focus may be directed to ECR for fast track review. Similarly, articles deemed too clinical for ECR and more appropriate for Gastroenterology may be fast tracked through Gastroenterology's review process. Both journals retain editorial independence and reserve the right to request additional changes, re-review, or reject manuscripts.

Experimental Dermatology provides a vehicle for the rapid publication of innovative and definitive reports, letters to the editor and review articles covering all aspects of experimental dermatology. Preference is given to papers of immediate importance to other investigators, either by virtue of their new methodology, experimental data or new ideas. The essential criteria for publication are clarity, experimental soundness and novelty. Letters to the editor related to published reports may also be accepted, provided that they are short and scientifically relevant to the reports mentioned, in order to provide a continuing forum for discussion. Review articles represent a state-of-the-art overview and are invited by the editors. Colour illustrations will be accepted free of charge.

Experimental Gerontology is a multidisciplinary journal for the publication of work from all areas of biogerontology, with an emphasis on studies focused at the systems level of investigation, such as whole organisms (e.g. invertebrate genetic models), immune, endocrine and cellular systems, as well as whole population studies (e.g. epidemiology). The journal also publishes studies into the behavioural and cognitive consequences of aging, where a clear biological causal link is implicated.Studies aimed at bridging the gap between basic and clinical aspects of gerontology, such as papers on the basic aspects of age-related diseases, are welcomed, as is research orientated toward the modulation of the aging process.Manuscripts on social aspects of aging and reports on clinical studies do not fall within the scope of the journal.In addition to original research manuscripts, short reports, reviews, mini-reviews, commentaries, perspectives, meeting reports and opinions on controversial subjects are published."Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Initial review of manuscripts averages under 4 weeksArticles published online from 5 days after acceptanceUnrivalled access to 10 million healthcare professionals through ScienceDirectOver 280,000 article downloads in 2012Impact factor of 2.905 (© Thomson Reuters Journal Citation Reports 2012)Experimental Hematology publishes original research reports (regular and fast-track submissions), reviews, perspectives, letters to the editor, and abstracts of the annual meeting of ISEH - Society for Hematology and Stem Cells. We welcome manuscripts describing basic in vitro and in vivo research centered on normal and malignant hematopoiesis as well as non-malignant hematologic diseases. Submissions focused on non-hematopoietic stem cells (e.g. mesenchymal stem cells, embryonic stem cells and induced pluripotent stems) with potential relevance to hematopoiesis are also welcome, as are studies involving experimental or early phase clinical cell transplantation. Studies employing genomic and systems biology approaches to the study of normal and malignant hematopoiesis are strongly encouraged, as are those employing model organisms.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Experimental Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology with emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings.Experimental Hematology & Oncology aims to publish original work, hypothesis, commentaries and timely reviews in the closely related fields of hematology and oncology.With open access, rapid turnaround time from submission to publication and online live comments from readers, Experimental Hematology & Oncology will strive to be the hub for disseminating new knowledge and discussing controversial topics for both basic scientists and busy clinicians in the field of hematology and oncology.

Scope and subject areas Experimental Physiology publishes Research Papers which report the results of original research in most areas of physiology (follow link below for table). These are normally limited to 6,000 words including legends and references Papers should embrace the journal's orientation of translation and integration. Specifically, we are keen to receive manuscripts that deal with both physiological and pathophysiological questions that investigate gene/protein function using molecular, cellular and whole animal approaches. In addition pertinent methodological papers are encouraged as are manuscripts that use computational models to further our understanding of physiological processes. For full details on the scope and subject areas covered click here.

Publishing outstanding articles from all fields of endocrinology and diabetology, from molecular biology to clinical research in 10 issues annually, this journal is an outsanding resource. Since being published in English in 1983, both the impact factor and popularity of this journal have grown steadily, reflecting the importance of this publication within its field.Case reports, original contributions and short communications appear in each issue along with reviews addressing current topics. In addition, supplementary issues are published each year presenting abstracts or proceedings of national and international scientific meetings.Celebrating its 80th anniversary in 2008, the journal was initially published in German, and is still the oldest endocrinological periodical in the German-language market.

Under new editorial leadership, Experimental and Molecular Pathology presents original articles on disease processes in relation to structural and biochemical alterations in mammalian tissues and fluids and on the application of newer techniques of molecular biology to problems of pathology in humans and other animals. The journal also publishes selected interpretive synthesis reviews by bench level investigators working at the "cutting edge" of contemporary research in pathology. In addition, special thematic issues present original research reports that unravel some of Nature's most jealously guarded secrets on the pathologic basis of disease.Research Areas include:• Stem cells• Neoangiogenesis• Molecular diagnostics• Polymerase chain reaction• In situ hybridization• DNA sequencing• Cell receptors• Carcinogenesis• Pathobiology of neoplasia• Complex infectious diseases• Transplantation• Cytokines• Flow cytomeric analysis• Inflammation• Cellular injury• Immunology and hypersensitivity• AthersclerosisBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

The international multidisciplinary journal is devoted to the publication of studies covering the whole range of experimental research on disease processes and toxicology including cell biological investigations. Its aim is to support progress in the interdisciplinary cooperation of researchers working in pathobiology, toxicology, and cell biology independent of the methods applied. During the past decades increasing attention has been paid to the importance of toxic influence in the pathogenesis of human and animal diseases. This is why Experimental and Toxicologic Pathology meets the urgent need for an interdisciplinary journal felt by a wide variety of experts in medicine and biology, including pathologists, toxicologists, biologists, physicians, veterinary surgeons, pharmacists, and pharmacologists working in academic, industrial or clinical institutions.

Expert Opinion on Biological Therapy ranks #42 of 160 in the Biotechnology & Applied Microbiology category and #30 of 106 in the Medicine, Research & Experimental category in the 2009 ISI Journal Citation Reports.Expert Opinion on Biological Therapy (ISSN 1471-2598 [print], 1744-7682 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on all aspects of biological therapy, providing expert opinion on the scope for future development.The Editors welcome: * Reviews covering gene therapy and gene transfer technologies; therapeutic peptides and proteins; vaccines and antibodies; cell- and tissue-based therapies * Drug Evaluations reviewing the clinical data on a particular biological agent * Original research papers reporting the results of clinical investigations on biological agents and biotherapeutic-based studies with a strong link to clinical practiceThe audience consists of scientists and managers in the healthcare and biopharmaceutical industry and others closely involved in the development of biological therapy for the treatment of human disease.